| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |